Bao Zhong Zhang

Kunming Biomedical International Ltd. specializes in non human primate disease models. The firm expertise in developing and running specialized primate animal models to test drug candidates and medical devices for its pharmacological effects and biocompatible repairs. It specializes in vivo pharmacology, clinical chemistry and bio analytics, drug metabolism and pharmacokinetics, non-GLP toxicology and safety pharmacology, and histology and pathology. The company was founded in 2006 and is headquartered in Kunming, China.

Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA.

HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China.